A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?

Author： Hill S.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.11, 2003-01, pp. : 761-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic evaluations alongside phase III trials?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Utilisation of Foreign Clinical Data in Japanese New Drug Approval Review: On What Basis Did the Regulatory Agency Accept Them?

By Shunsuke Ono  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 159-165

Adis International

Access to resources Recommend Favorite

Prasugrel FDA approval decision: for whom is the timing out?

By  

Inpharma, Vol. 1, Iss. 1644, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Is the UK government delaying approval for new cancer drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Etoricoxib: equipped with MEDAL-winning safety data?

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite